Progress in studying the impact of hyperlipidemia and statins on rotator cuff injury and repair.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 21 08 2023
accepted: 12 10 2023
medline: 16 11 2023
pubmed: 15 11 2023
entrez: 15 11 2023
Statut: epublish

Résumé

This review delves into the intersection of two prevalent conditions, hyperlipidemia and rotator cuff injuries, both of which bear substantial healthcare burdens. Our investigation begins with an exploration of rotator cuff injuries, common musculoskeletal disorders that severely impair shoulder functionality and quality of life. These injuries are notably pervasive among sports enthusiasts and the older adult, with an incidence rate estimated at 5-10% in the general population. Despite their widespread occurrence and the diverse, multifactorial etiological factors, effective treatment strategies remain elusive. We then examine hyperlipidemia, a metabolic disorder affecting approximately 40% of the global adult population. Characterized by elevated levels of cholesterol and triglycerides, hyperlipidemia can precipitate severe cardiovascular complications and presents a significant socioeconomic burden. Although current management strategies encompass lifestyle modifications and pharmacological interventions, the condition remains a formidable health challenge. Central to this review is the exploration of a potential association between hyperlipidemia and rotator cuff injuries. We aim to synthesize the current understanding of hyperlipidemia's role in the pathophysiology of rotator cuff injuries, thereby offering fresh insights into their common etiological underpinnings, potential therapeutic targets, and drugs, such as Statins. The influence of other lipid-lowering therapeutics on tendon health is also considered, and further research into the molecular pathways and potential therapeutic benefits of these drugs is required. This pursuit aligns with broader efforts to enhance patient outcomes, minimize healthcare burdens, and contribute to the global understanding of these prevalent conditions.

Identifiants

pubmed: 37965515
doi: 10.3389/fpubh.2023.1279118
pmc: PMC10641405
doi:

Substances chimiques

Hydroxymethylglutaryl-CoA Reductase Inhibitors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1279118

Informations de copyright

Copyright © 2023 Qian, Huang, Wan, Zhou, Feng, Xu, Luo and Wang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

World J Stem Cells. 2021 Nov 26;13(11):1762-1782
pubmed: 34909122
Am J Sports Med. 2017 Sep;45(11):2524-2531
pubmed: 28609119
PLoS One. 2017 Mar 6;12(3):e0172797
pubmed: 28264197
Am J Manag Care. 2017 Jun;23(9 Suppl):S139-S148
pubmed: 28978219
Lipids Health Dis. 2020 Feb 8;19(1):23
pubmed: 32035485
Knee Surg Sports Traumatol Arthrosc. 2017 Jun;25(6):1884-1891
pubmed: 26275370
Sci Rep. 2019 Nov 29;9(1):17958
pubmed: 31784541
Am J Sports Med. 2011 Oct;39(10):2099-107
pubmed: 21813440
Mil Med Res. 2023 Aug 18;10(1):39
pubmed: 37592367
Stem Cell Res Ther. 2020 Mar 20;11(1):131
pubmed: 32197645
Br J Sports Med. 2010 Oct;44(13):948-51
pubmed: 19357120
Am J Sports Med. 2020 Aug;48(10):2518-2524
pubmed: 32692629
Biomater Res. 2022 Aug 19;26(1):39
pubmed: 35986376
J Rehabil Med. 2019 Oct 4;51(9):627-637
pubmed: 31489438
J Occup Environ Med. 2017 Feb;59(2):154-160
pubmed: 28002354
Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R233-40
pubmed: 16081881
J Shoulder Elbow Surg. 2017 Dec;26(12):2086-2090
pubmed: 28735844
J Shoulder Elbow Surg. 2021 Nov;30(11):2465-2474
pubmed: 34116193
Chem Biol Interact. 2015 Feb 25;228:79-87
pubmed: 25619641
JCI Insight. 2022 Sep 22;7(18):
pubmed: 35943796
Ann Phys Rehabil Med. 2023 Feb;66(1):101631
pubmed: 35257948
Food Chem Toxicol. 2015 Mar;77:50-7
pubmed: 25544391
Curr Rev Musculoskelet Med. 2020 Oct;13(5):553-560
pubmed: 32488624
Scand J Med Sci Sports. 2021 Sep;31(9):1822-1831
pubmed: 33963621
Am J Sports Med. 2023 Jul;51(8):1988-1996
pubmed: 37259963
J Inflamm Res. 2021 Mar 23;14:1055-1068
pubmed: 33790620
Can J Physiol Pharmacol. 2017 Apr;95(4):333-339
pubmed: 28112540
Am J Sports Med. 2017 Nov;45(13):2948-2954
pubmed: 28787187
Int Orthop. 2010 Jun;34(5):689-94
pubmed: 19434410
Med Hypotheses. 2016 Mar;88:12-7
pubmed: 26880627
Am J Sports Med. 2014 Dec;42(12):2869-76
pubmed: 25184246
Am J Sports Med. 2015 Sep;43(9):2126-32
pubmed: 26085191
J Orthop Surg Res. 2019 Jun 10;14(1):172
pubmed: 31182124
Discov Med. 2014 Jul-Aug;18(97):7-14
pubmed: 25091484
Mol Cell Biochem. 2023 Aug;478(8):1887-1898
pubmed: 36576716
J Orthop Res. 2020 Jan;38(1):192-201
pubmed: 31444797
Am J Sports Med. 2019 Nov;47(13):3247-3255
pubmed: 31560856
J Cell Physiol. 2019 Aug;234(10):18017-18028
pubmed: 30825206
Am J Sports Med. 2020 Oct;48(12):3042-3050
pubmed: 32931300
J Biomater Appl. 2021 Aug;36(2):210-218
pubmed: 33779364
J Shoulder Elbow Surg. 2011 Sep;20(6):917-27
pubmed: 21612944
J Shoulder Elbow Surg. 2018 Jun;27(6):1012-1020
pubmed: 29290609
J Shoulder Elbow Surg. 2021 Jan;30(1):9-15
pubmed: 32838953
Bioact Mater. 2022 Jan 23;17:344-359
pubmed: 35386460
J Bone Miner Metab. 2022 Mar;40(2):348-356
pubmed: 35059890
Am J Sports Med. 2023 Apr;51(5):1267-1276
pubmed: 36917828
Orthop Traumatol Surg Res. 2015 Oct;101(6 Suppl):S269-73
pubmed: 26321466
Am J Sports Med. 2022 Jun;50(7):2032-2041
pubmed: 34138660

Auteurs

Yinhua Qian (Y)

Department of Orthopaedics, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, Jiangsu, China.

Haoqiang Huang (H)

Department of Orthopaedics, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, Jiangsu, China.

Renwen Wan (R)

Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Yu Zhou (Y)

Department of Orthopaedics, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, Jiangsu, China.

Xinting Feng (X)

Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Feng Xu (F)

Department of Orthopaedics, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, Jiangsu, China.

Zhiwen Luo (Z)

Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Qing Wang (Q)

Department of Orthopaedics, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, Jiangsu, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH